ALPHATEC HOLDINGS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
ALPHATEC HOLDINGS, INC. (ATEC) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.82 per share for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2019-03-29
- ALPHATEC HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2018 was -$0.82.
- ALPHATEC HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2017 was -$1.25.
- ALPHATEC HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2016 was -$3.06.
- ALPHATEC HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2015 was -$20.64.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|
| 2018-12-31 | -$0.82 10-K · filed 2019-03-29 |
| 2017-12-31 | -$1.25 10-K · filed 2019-03-29 |
| 2016-12-31 | -$3.06 10-K · filed 2018-03-09 |
| 2015-12-31 | -$20.64 10-K · filed 2017-03-31 |
| 2014-12-31 | -$0.33 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |